Literature DB >> 3585666

Hirschsprung's disease: a comparison of the nervous control of ganglionic and aganglionic smooth muscle in vitro.

L T Larsson, G Malmfors, C Wahlestedt, S Leander, R Håkanson.   

Abstract

Specimens from aganglionic (constricted) and ganglionic (dilated) gut were obtained from nine patients with Hirschsprung's disease. Transmural nerve stimulation of ganglionic smooth muscle in vitro evoked an initial relaxation followed by a contraction. This contraction was reduced but not abolished by atropine and it was further reduced by substance P antagonists. Guanethidine did not affect the electrically evoked responses. In aganglionic smooth muscle, an atropine-sensitive contraction but no initial relaxation was registered. Tetrodotoxin abolished all responses to electrical stimulation in both ganglionic and aganglionic specimens. Application of carbachol or substance P produced contraction and the adrenergic agonist isoprenaline or vasoactive intestinal peptide produced relaxation in ganglionic as well as aganglionic specimens. Two other gut neuropeptides, neuropeptide Y and galanin, were without effect. The results do not indicate a different receptor set up in ganglionic v aganglionic gut. The results are compatible with a lack of noncholinergic nonadrenergic inhibitory neurons in the aganglionic gut.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585666     DOI: 10.1016/s0022-3468(87)80263-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Increased smooth muscle contractility of intestine in the genetic null of the endothelin ETB receptor: a rat model for long segment Hirschsprung's disease.

Authors:  K-J Won; S Torihashi; M Mitsui-Saito; M Hori; K Sato; T Suzuki; H Ozaki; H Karaki
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  The distribution and co-localization of nitric oxide synthase and vasoactive intestinal polypeptide in nerves of the colons with Hirschsprung's disease.

Authors:  R Guo; O Nada; S Suita; T Taguchi; K Masumoto
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 3.  Hirschprung's disease.

Authors:  P B Sullivan
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

4.  Peptidergic innervation of the internal anal sphincter in Hirschsprung's disease.

Authors:  B Husberg; M Schultzberg
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

5.  A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease.

Authors:  Z Shen; L T Larsson; G Malmfors; A Absood; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1992-08       Impact factor: 5.249

6.  Intestinal endocrine cells in Hirschsprung's disease. No reduction in density in aganglionic compared with ganglionic segment.

Authors:  L T Larsson; F Sundler; R Ekman
Journal:  Int J Colorectal Dis       Date:  1990-08       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.